Miocić Snjezana, Filocamo Mirella, Dominissini Silvia, Montalvo Anna Lisa E, Vlahovicek Kristian, Deganuto Marta, Mazzotti Raffaella, Cariati Roberta, Bembi Bruno, Pittis Maria Gabriela
Unità di Malattie Metaboliche, I.R.C.C.S. Burlo Garofolo, Trieste, Laboratorio Diagnosi Pre-Postnatale Malattie Metaboliche, I.R.C.C.S.G. Gaslini, Genova and International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Hum Mutat. 2005 Jan;25(1):100. doi: 10.1002/humu.9301.
Gaucher disease (GD) is the most frequent lysosomal glycolipid storage disorder due to an autosomal recessive deficiency of acid beta-glucosidase characterized by the accumulation of glucocerebroside. In this work we carried out the molecular analysis of the glucocerebrosidase gene (GBA) in 58 unrelated patients with GD type 1. We identified five novel genetic alterations: three missense changes c.187G>A (p.D63N), c.473T>G (p.I158S), c.689T>A (p.V230E), a gene-pseudogene recombinant allele and a non-pseudogene-derived complex allele [c.1379G>A;c.1469A>G] encoding [p.G460D;p.H490R]. All mutant alleles were present as compound heterozygotes in association with c.1226A>G (p.N409S), the most common mutation in GD1. The missense mutant proteins were expressed in vitro in COS-1 cells and analyzed by enzyme activity, protein processing and intracellular localization. Functional studies also included the c.662C>T (p.P221L) mutation recently reported in the Spanish GD population (Montfort et al., 2004). The missense mutant alleles retained an extremely low residual enzyme activity with respect to wild type; the complex allele expressed no activity. Processing of the mutant proteins was unaltered except for c.473T>G which was differently glycosylated due to the exposition of an additional glycosylation site. Immunofluorescence studies showed that protein trafficking into the lysosomes was unaffected in all cases. Finally, the characterization of the novel recombinant allele identified a crossover involving the GBA gene and pseudogene between intron 5 and exon 7.
戈谢病(GD)是最常见的溶酶体糖脂贮积症,由于常染色体隐性遗传导致酸性β-葡萄糖苷酶缺乏,其特征为葡萄糖脑苷脂蓄积。在本研究中,我们对58例无关的1型戈谢病患者的葡萄糖脑苷脂酶基因(GBA)进行了分子分析。我们鉴定出5种新的基因改变:3种错义变化c.187G>A(p.D63N)、c.473T>G(p.I158S)、c.689T>A(p.V230E),一个基因-假基因重组等位基因和一个非假基因衍生的复合等位基因[c.1379G>A;c.1469A>G],编码[p.G460D;p.H490R]。所有突变等位基因均以复合杂合子形式存在,并与c.1226A>G(p.N409S)相关联,后者是1型戈谢病中最常见的突变。错义突变蛋白在COS-1细胞中进行体外表达,并通过酶活性、蛋白加工和细胞内定位进行分析。功能研究还包括最近在西班牙戈谢病患者群体中报道的c.662C>T(p.P221L)突变(Montfort等人,2004年)。与野生型相比,错义突变等位基因保留的残余酶活性极低;复合等位基因无活性表达。除了c.473T>G由于额外糖基化位点的暴露导致糖基化不同外,突变蛋白的加工未改变。免疫荧光研究表明,在所有情况下,蛋白向溶酶体的转运均未受影响。最后,对新的重组等位基因的表征确定了一个涉及GBA基因和假基因在内含子5和外显子7之间的交叉。